<DOC>
	<DOCNO>NCT00606411</DOCNO>
	<brief_summary>The purpose study learn safety effectiveness oral ( take mouth ) topiramate treat Sleep-Related Eating Disorder ( SRED ) .</brief_summary>
	<brief_title>Efficacy Safety Topiramate Treatment Sleep-Related Eating Disorder</brief_title>
	<detailed_description>This single center , 13-week , outpatient , randomize , double-blind , placebo-controlled , parallel group , pilot study topiramate subject Sleep-Related Eating Disorder ( SRED ) . The primary objective study investigate efficacy safety topiramate compare placebo treatment Sleep-Related Eating Disorder . SRED disorder consist control eat night little awareness event . In study compare topiramate placebo . A placebo pill look exactly like study drug , active drug . Topamax ( topiramate ) approve U.S. Food Drug Administration ( FDA ) therapy epilepsy , topiramate approve FDA SRED .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Adults 1865 Diagnosis SRED Must able swallow capsule follow instruction Women pregnant lactate Other sleep disorder Kidney Liver disease Night shift worker Previous history Topiramate Topamax use condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Sleep-Related Eating Disorder</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Parasomnia</keyword>
</DOC>